SCHEDULE 13D/A: L-5 Healthcare Partners and Paul Segal Update 5.3% Stake in Alphatec Holdings
Beneficial Ownership Amendment
L-5 Healthcare Partners, LLC and Paul Segal have filed an Amendment No. 9 to their Schedule 13D, reporting a continued beneficial ownership of 5.3% in Alphatec Holdings, Inc.
Summary
- L-5 Healthcare Partners, LLC and Paul Segal collectively beneficially own 7,699,315 shares of Alphatec Holdings, Inc. Common Stock.
- This ownership represents 5.3% of the Issuer's outstanding Common Stock.
- The calculation of the percentage is based on 144,149,232 shares of Common Stock outstanding as of February 19, 2025, as reported in the Issuer's Form 10-K filed on February 25, 2025, plus 1,133,160 shares of Common Stock issuable upon the exercise of a warrant.
- L-5 Healthcare Partners directly holds 6,556,155 shares of Common Stock and 1,133,160 shares issuable upon warrant exercise, totaling 7,699,315 shares.
- Paul Segal is deemed a beneficial owner due to his relationship with L-5, but disclaims beneficial ownership except for his indirect pecuniary interest.
- This filing is Amendment No. 9 to a previously filed Schedule 13D, indicating an ongoing reporting requirement for their stake.
Sentiment
Score: 5
Explanation: The document is a routine beneficial ownership update (Amendment No. 9) and does not contain information that would significantly alter the sentiment towards the company. It simply confirms an existing ownership stake.
Future Outlook
NA
Industry Context
This filing is a routine disclosure of beneficial ownership, common for investors holding more than 5% of a public company's stock. It does not provide specific insights into broader industry trends or competitive dynamics beyond the ownership structure of Alphatec Holdings, Inc., a medical technology company.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant ownership stake held by L-5 Healthcare Partners, LLC and Paul Segal, confirming their continued interest in the company.
Key Dates
| Date | Description |
|---|---|
| 2025-02-19 | Date as of which 144,149,232 shares of Common Stock were outstanding, as reported in the Issuer's Form 10-K. |
| 2025-02-25 | Date the Issuer's Form 10-K was filed with the SEC, reporting outstanding shares. |
| 2025-04-09 | Date of event which required the filing of this statement (Schedule 13D Amendment No. 9). |
| 2025-04-11 | Date the Schedule 13D Amendment No. 9 was signed and filed. |
Keywords
Alphatec Holdings Inc, L-5 Healthcare Partners LLC, Paul Segal, Schedule 13D, Beneficial Ownership, Common Stock, SEC Filing, Investment, Healthcare
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.